Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders.

Seidlitz J, Nadig A, Liu S, Bethlehem RAI, Vértes PE, Morgan SE, Váša F, Romero-Garcia R, Lalonde FM, Clasen LS, Blumenthal JD, Paquola C, Bernhardt B, Wagstyl K, Polioudakis D, de la Torre-Ubieta L, Geschwind DH, Han JC, Lee NR, Murphy DG, Bullmore ET, Raznahan A. · 2020

Read Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders. by Seidlitz J, Nadig A, Liu S, Bethlehem RAI, Vértes PE, Morgan SE, Váša F, Romero-Garcia R, Lalonde FM, Clasen LS, Blumenthal JD, Paquola C, Bernhardt B, Wagstyl K, Polioudakis D, de la Torre-Ubieta L, Geschwind DH, Han JC, Lee NR, Murphy DG, Bullmore ET, Raznahan A. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7335069.txt.

Introduction

Seidlitz and co-authors link gene activity maps to brain changes in neurogenetic disorders, in Nature Communications. Such disorders run in families and alter brain anatomy in region-specific patterns. The team studied six disorders caused by copy number variants, where chunks of DNA are missing or doubled.

For each disorder, the pattern of cortical change in young patients matched where the affected genes are active in healthy adult brains. They then converted gene activity data into cell-type maps. That step tied each disorder's change pattern to specific cell classes and the genes those cells express. The organizing rules they uncover could help screen candidate genes and treatments. Readers get a bridge from DNA risk to brain anatomy.

Catalog record

CREATORSeidlitz J, Nadig A, Liu S, Bethlehem RAI, Vértes PE, Morgan SE, Váša F, Romero-Garcia R, Lalonde FM, Clasen LS, Blumenthal JD, Paquola C, Bernhardt B, Wagstyl K, Polioudakis D, de la Torre-Ubieta L, Geschwind DH, Han JC, Lee NR, Murphy DG, Bullmore ET, Raznahan A.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE93 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7335069

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders By Jakob Seidlitz, Ajay Nadig, Siyuan Liu, Richard A. I. Bethlehem, Petra E. Vértes, Sarah E. Morgan, František Váša, Rafael Romero-Garcia, François M. Lalonde, Liv S. Clasen, Jonathan D. Blumenthal, Casey Paquola Published in: Nature Communications DOI: 10.1038/s41467-020-17051-5 ABSTRACT Neurodevelopmental disorders have a heritable component and are associated with region specific alterations in brain anatomy. However, it is unclear how genetic risks for neurodevelopmental disorders are translated into spatially patterned brain vulnerabilities. Here, we integrated cortical neuroimaging data from patients with neurodevelopmental disorders caused by genomic copy number variations (CNVs) and gene expression data from healthy subjects. For each of the six investigated disorders, we show that spatial patterns of cortical anatomy changes in youth are correlated with cortical spatial expression of CNV genes in neurotypical adults. By transforming normative bulk-tissue cortical expression data into cell-type expression maps, we link anatomical change maps in each analysed disorder to specific cell classes as well as the CNV-region genes they express. Our findings reveal organizing principles that regulate the mapping of genetic risks onto regional brain changes in neurogenetic disorders. Our findings will enable screening for candidate molecular mechanisms from readily available neuroimaging data. INTRODUCTION Neurodevelopmental disorders such as autism and schizophrenia are highly heritable, and associated with spatially selective changes in brain structure and function1–3, which remain poorly understood in mechanistic terms. In particular, it remains unclear how genetic risks translate into the spatial patterns of altered brain anatomy that have been reported in neurodevelopmental disorders. Clarifying factors that shape regional brain vulnerability to genetic risks would help to advance the translational medicine of neurodevelopmental disorders. However, progress in this area is complicated by several issues including (i) the etiological heterogeneity of behaviorally defined neurodevelopmental disorders4, (ii) the vast search space of candidate biological features that could determine regional brain vulnerability5, and (iii) lack of access to spatiotemporally comprehensive postmortem brain tissue from patients. Recent experimental work in mice has suggested an organizing principle for regional brain vulnerability to genetic risks that may apply in human neurodevelopmental disorders. Specifically, the spatial patterning of neuroanatomical changes in MRI brain scans from mutant mouse models with disruptions of neurodevelopmental genes can be predicted by intrinsic expression gradients of those genes in the brains of wild-type mice6,7. Strikingly, this spatial coupling was recovered using expression data from adult wild-type mice—despite the likely operation of mutant allele effects much earlier in brain development. These murine data therefore propose a transcriptional vulnerability model for the spatial patterning of altered brain anatomy in genetically determined disorders of brain development and further suggest that evidence for this model could be recovered even if intrinsic expression gradients are being measured in adulthood. To date, however, tests of the transcriptional vulnerability model in humans have only been available from studies of brain anatomy patients with idiopathic autism and schizophrenia8–11. Because the genetic basis of disease is unknown in idiopathic cases, it is not possible to determine if observed spatial patterns of neuroanatomical change are related to normative expression gradients for the causal genes. Here, we conduct a genetically informed test of the transcriptional vulnerability model in humans. To achieve this test, we study youth with known genomic dosage variations that increase risk for one or more adverse neurodevelopmental outcomes such as intellectual disability, specific learning disability, autism spectrum disorder, attention deficit hyperactivity disorder and schizophrenia: Down syndrome12 (trisomy 21), sex chromosome aneuploidies13 (XO, XXX, XXY, XYY, XXYY), Velocardiofacial syndrome14 (del22q11) and WAGR syndrome15 (del11p13). These diverse genetically defined disorders encompass both gains and losses of genetic material, which range in size from subchromosomal copy number variations (CNVs) to full chromosomal aneuploidies (henceforth collectively referred to as CNVs)—thereby providing a powerful test for generalizability of the transcriptional vulnerability model. We also seek to refine and apply this transcriptional vulnerability model, by testing if the intrinsic gene expression gradients hypothesized to guide neuroanatomical disruptions can themselves be rooted in spatial patterning of the human brain by different cell-types. Such grounding of regional transcriptional vulnerability in cell-type composition could provide a principled framework for nominating specific genes within specific cell-types that may account for altered anatomy in a given brain region to a given neurogenetic disorder. RESULTS Mapping altered cortical anatomy in six different CNV conditions We assembled a total of 518 structural magnetic resonance imaging (sMRI) brain scans from matched case−control cohorts spanning eight different neurogenetic disorders: XXX, XXY, XYY, XXYY, trisomy 21 (Down syndrome), X-monosomy (Turner syndrome), del22q11.2 (Velocardiofacial syndrome, VCFS) and del11p13 (Wilms Tumor−Aniridia syndrome, WAGR) (Supplementary Table 1; total N = 231 patients, 287 controls). Because the distinct gene sets defining each of these CNV disorders is known, we were able to conduct a series of strict, independent tests of the transcriptional vulnerability model in humans. Specifically, we asked if the map of cortical anatomy change in each of the six CNV states represented by these disorders (henceforth: +X, +Y, +21, −X, −22q11, −11p13) was preferentially correlated with spatial patterns of expression for the known genes that defined that disorder. Each case−control pair was scanned on the same MRI machine using the same image-acquisition parameters. A map of cortical anatomy change was made for each of the six CNVs vs. matched controls using morphometric similarity (MS) mapping. Rather than considering individual anatomical features such as cortical thickness, area, and curvature, MS mapping combines information across multiple cortical features to estimate a network of MS between pairs of cortical regions within an individual brain. This network can be summarized as a person-specific map of mean MS for each cortical region (relative to all other cortical regions). Group-level comparisons were used to determine the spatial pattern of cortical MS change associated with each CNV (Fig. 1a, Supplementary Fig. 1; see “Methods”). Our use of MS mapping in this study was motivated by two key considerations: (i) CNV disorders have dissociable impacts on different anatomical features of the cortical sheet1, and MS mapping provides a means of integrating this rich information, (ii) cortical MS gradients are strongly aligned with the molecular and cytological aspects of cortical patterning that we sought to probe in our test of the transcriptional vulnerability model16. Further information on topological and network features of MSNs is provided in the original paper16. To compare results from the use of MSNs vs. classical single-feature approaches to cortical morphometry, we also generated supplementary maps of anatomical change in each CNV for all of the individual cortical features that are combined in MS mapping (Supplementary Fig. 2a). To test for differential contribution of single cortical features to observed MS changes in each CNV, we recomputed CNV-specific MS change maps with exclusion of each individual cortical feature prior to MSN construction and then determined which of these single-feature exclusions most change the topography of observed MS change for each CNV. This leave-one-out procedure showed that mean curvature (+X, +Y) and gray matter volume (−X, +21,−22q11,−11p13) were the features that most contributed to the topography of observed MS changes (Supplementary Fig. 2b).Fig. 1Transcriptomic specificity of neuroanatomical effects.a Schematic outlining the main imaging-transcriptomic enrichment analyses and statistical tests. b (left) Surface projections of T-statistics (z-scored for plotting purposes) for CNV effects on regional morphometric

Read the complete text